GCG and obesity due to melanocortin 4 receptor deficiency: Physiologically, GLP-1 is known to control body weight gain inhibiting appetite and delaying gastric emptying, and GLP-1 synthetic orally-active receptor agonist semaglutide has now been used to control type-2 diabetes and obesity [111,112,113,114].